Brauer Syndrome (Setleis Syndrome)

Brauer Syndrome (Setleis Syndrome)

Brauer syndrome, also known as Setleis syndrome or focal facial dermal dysplasia type III (FFDD3), is a rare genetic condition characterized by distinctive facial features and dermal abnormalities. It belongs to the group of focal facial dermal dysplasias.

Key Points

  • Rare autosomal recessive inheritance pattern
  • Characterized by distinctive facial features present at birth
  • Associated with TWIST2 gene mutations
  • Part of the focal facial dermal dysplasia spectrum
  • Variable expressivity among affected individuals

Epidemiology

  • Extremely rare disorder with fewer than 50 reported cases
  • Affects males and females equally
  • Higher prevalence in Puerto Rican populations
  • Can occur in any ethnic group

Historical Context

  • First described by Brauer in 1929
  • Further characterized by Setleis in 1963
  • Genetic basis identified in the early 2000s
  • Classification as FFDD3 established in 2011

Clinical Features

Facial Features

  1. Primary Characteristics:
    • Bilateral temporal marks resembling forceps marks
    • Leonine appearance with coarse features
    • Absent or sparse eyelashes
    • Multiple periocular papules
    • Puckered chin
  2. Secondary Features:
    • Upslanting palpebral fissures
    • Flattened nasal bridge
    • Thick vermilion of lips
    • Facial asymmetry
    • Abnormal hair growth patterns

Dermatological Manifestations

  • Skin Findings:
    • Bitemporal scar-like lesions
    • Dermal atrophy or aplasia
    • Abnormal skin texture
    • Altered pigmentation
  • Hair Abnormalities:
    • Sparse or absent eyelashes
    • Abnormal eyebrow patterns
    • Unusual scalp hair distribution
    • Variable body hair patterns

Associated Features

  • Growth and development usually normal
  • Normal intelligence
  • Possible ocular complications
  • Dental anomalies in some cases
  • Potential hearing impairment

Diagnosis & Genetics

Diagnostic Approach

  • Clinical Diagnosis:
    • Based on characteristic facial features
    • Family history assessment
    • Physical examination
    • Documentation of temporal lesions
  • Genetic Testing:
    • TWIST2 gene sequencing
    • Next-generation sequencing panels
    • Whole exome sequencing if needed

Molecular Genetics

  • TWIST2 Gene:
    • Located on chromosome 2q37.3
    • Basic helix-loop-helix transcription factor
    • Role in mesodermal development
    • Multiple pathogenic variants identified
  • Inheritance Pattern:
    • Autosomal recessive transmission
    • Variable expressivity
    • Genetic counseling important

Differential Diagnosis

  • Other focal facial dermal dysplasias
  • Bitemporal aplasia cutis congenita
  • Kabuki syndrome
  • Ablepharon macrostomia syndrome
  • Ectodermal dysplasias

Histopathology

  • Dermal hypoplasia
  • Abnormal collagen organization
  • Reduced elastic fibers
  • Altered appendageal structures

Management

Multidisciplinary Care

  • Core Team Members:
    • Clinical geneticist
    • Dermatologist
    • Plastic surgeon
    • Ophthalmologist
    • Pediatrician
  • Support Services:
    • Genetic counseling
    • Psychological support
    • Social work services
    • Educational support

Treatment Options

  1. Dermatological Care:
    • Skin protection measures
    • Moisturizing regimens
    • Treatment of complications
    • Scar management
  2. Surgical Interventions:
    • Reconstructive procedures
    • Scar revision
    • Aesthetic improvements
    • Timing considerations
  3. Ophthalmologic Care:
    • Regular eye examinations
    • Management of corneal exposure
    • Protection of ocular surface
    • Treatment of complications

Research & Development

Current Research

  • Molecular Studies:
    • TWIST2 function investigation
    • Genetic modifier studies
    • Developmental pathway research
    • Animal models
  • Clinical Research:
    • Natural history studies
    • Treatment outcome analysis
    • Quality of life assessments
    • Genotype-phenotype correlations

Future Directions

  • Gene therapy possibilities
  • Novel treatment approaches
  • Improved diagnostic methods
  • Patient registry development

Prognosis & Care

Long-term Outcomes

  • Normal life expectancy
  • Variable cosmetic concerns
  • Psychosocial challenges
  • Quality of life impact

Monitoring Guidelines

  • Regular Follow-up:
    • Annual genetic assessment
    • Biannual dermatology review
    • Regular ophthalmology checks
    • Developmental monitoring
  • Specific Monitoring:
    • Growth parameters
    • Ocular complications
    • Skin changes
    • Psychosocial adjustment

Support Resources

  • Patient support groups
  • Educational resources
  • Family counseling
  • Community services
Further Reading


Powered by Blogger.